194 related articles for article (PubMed ID: 27292631)
1. PI3K/AKT Signaling Regulates H3K4 Methylation in Breast Cancer.
Spangle JM; Dreijerink KM; Groner AC; Cheng H; Ohlson CE; Reyes J; Lin CY; Bradner J; Zhao JJ; Roberts TM; Brown M
Cell Rep; 2016 Jun; 15(12):2692-704. PubMed ID: 27292631
[TBL] [Abstract][Full Text] [Related]
2. Targeting MLL Methyltransferases Enhances the Antitumor Effects of PI3K Inhibition in Hormone Receptor-positive Breast Cancer.
Jones RB; Farhi J; Adams M; Parwani KK; Cooper GW; Zecevic M; Lee RS; Hong AL; Spangle JM
Cancer Res Commun; 2022 Dec; 2(12):1569-1578. PubMed ID: 36970726
[TBL] [Abstract][Full Text] [Related]
3. Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A.
Petronikolou N; Longbotham JE; Fujimori DG
Biochemistry; 2020 Feb; 59(5):647-651. PubMed ID: 31985200
[TBL] [Abstract][Full Text] [Related]
4. Histone demethylase KDM5A inhibits glioma cells migration and invasion by down regulating ZEB1.
Dai B; Huang H; Guan F; Zhu G; Xiao Z; Mao B; Su H; Hu Z
Biomed Pharmacother; 2018 Mar; 99():72-80. PubMed ID: 29324315
[TBL] [Abstract][Full Text] [Related]
5. H3K4me3 Demethylase Kdm5a Is Required for NK Cell Activation by Associating with p50 to Suppress SOCS1.
Zhao D; Zhang Q; Liu Y; Li X; Zhao K; Ding Y; Li Z; Shen Q; Wang C; Li N; Cao X
Cell Rep; 2016 Apr; 15(2):288-99. PubMed ID: 27050510
[TBL] [Abstract][Full Text] [Related]
6. PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.
Toska E; Castel P; Chhangawala S; Arruabarrena-Aristorena A; Chan C; Hristidis VC; Cocco E; Sallaku M; Xu G; Park J; Minuesa G; Shifman SG; Socci ND; Koche R; Leslie CS; Scaltriti M; Baselga J
Cell Rep; 2019 Apr; 27(1):294-306.e5. PubMed ID: 30943409
[TBL] [Abstract][Full Text] [Related]
7. Cigarette sidestream smoke induces histone H3 phosphorylation via JNK and PI3K/Akt pathways, leading to the expression of proto-oncogenes.
Ibuki Y; Toyooka T; Zhao X; Yoshida I
Carcinogenesis; 2014 Jun; 35(6):1228-37. PubMed ID: 24398671
[TBL] [Abstract][Full Text] [Related]
8. Akt/PKB-mediated phosphorylation of Twist1 promotes tumor metastasis via mediating cross-talk between PI3K/Akt and TGF-β signaling axes.
Xue G; Restuccia DF; Lan Q; Hynx D; Dirnhofer S; Hess D; Rüegg C; Hemmings BA
Cancer Discov; 2012 Mar; 2(3):248-59. PubMed ID: 22585995
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of PI3K/AKT in tumor-related epigenetic regulation.
Yang Q; Jiang W; Hou P
Semin Cancer Biol; 2019 Dec; 59():112-124. PubMed ID: 30951826
[TBL] [Abstract][Full Text] [Related]
10. The histone demethylase KDM5A is required for the repression of astrocytogenesis and regulated by the translational machinery in neural progenitor cells.
Kong SY; Kim W; Lee HR; Kim HJ
FASEB J; 2018 Feb; 32(2):1108-1119. PubMed ID: 29212818
[TBL] [Abstract][Full Text] [Related]
11. Fine-tuning AKT kinase activity through direct lysine methylation.
Guo J; Wei W
Cell Cycle; 2019 May; 18(9):917-922. PubMed ID: 31050579
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism.
Torres IO; Kuchenbecker KM; Nnadi CI; Fletterick RJ; Kelly MJ; Fujimori DG
Nat Commun; 2015 Feb; 6():6204. PubMed ID: 25686748
[TBL] [Abstract][Full Text] [Related]
15. Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
Gale M; Sayegh J; Cao J; Norcia M; Gareiss P; Hoyer D; Merkel JS; Yan Q
Oncotarget; 2016 Jun; 7(26):39931-39944. PubMed ID: 27224921
[TBL] [Abstract][Full Text] [Related]
16. Coordinated repression of cell cycle genes by KDM5A and E2F4 during differentiation.
Beshiri ML; Holmes KB; Richter WF; Hess S; Islam AB; Yan Q; Plante L; Litovchick L; Gévry N; Lopez-Bigas N; Kaelin WG; Benevolenskaya EV
Proc Natl Acad Sci U S A; 2012 Nov; 109(45):18499-504. PubMed ID: 23093672
[TBL] [Abstract][Full Text] [Related]
17. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
18. Increased progesterone receptor A expression in labouring human myometrium is associated with decreased promoter occupancy by the histone demethylase JARID1A.
Chai SY; Smith R; Fitter JT; Mitchell C; Pan X; Ilicic M; Maiti K; Zakar T; Madsen G
Mol Hum Reprod; 2014 May; 20(5):442-53. PubMed ID: 24442343
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
Wang F; Li L; Chen Z; Zhu M; Gu Y
Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic silencing mediated through activated PI3K/AKT signaling in breast cancer.
Zuo T; Liu TM; Lan X; Weng YI; Shen R; Gu F; Huang YW; Liyanarachchi S; Deatherage DE; Hsu PY; Taslim C; Ramaswamy B; Shapiro CL; Lin HJ; Cheng AS; Jin VX; Huang TH
Cancer Res; 2011 Mar; 71(5):1752-62. PubMed ID: 21216892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
